EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma

Aneta Szudy-Szczyrek iD, Radosław Mlak iD, Marcin Mazurek iD, Tomasz Krajka iD, Sylwia Chocholska iD, Paulina Bitkowska, Marta Jutrzenka iD, Michał Szczyrek, Iwona Homa-Mlak, Andrzej Krajka iD, Teresa Małecka-Massalska, Marek Hus

Cells · 2023

DOI: 10.3390/cells12071029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Aneta Szudy-Szczyrek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-059 Lublin, Poland. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Multiple Myeloma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The KIAA1524 gene encodes an oncoprotein, CIP2A, which inhibits the phosphorylation of the Akt kinase B, stabilizes the c-Myc protein, and, through that, promotes cancerogenesis. An increase in CIP2A expression has been observed in numerous solid tumors and hematologic malignancies, including multiple myeloma (MM). The aim of our study was to evaluate the clinical impact of the functional single nucleotide polymorphisms (SNP) of the KIAA1524 gene (rs2278911, 686C > T) in MM patients.

Methods

The study group consisted of 128 patients with de novo MM. EDTA venous blood samples were collected prior to the treatment. The SNPs were analyzed by Real-Time PCR with the use of specific Taqman probes.

Results

Multivariable analysis revealed that variables independently associated with shorter progression-free survival (PFS) included thrombocytopenia, delTP53 and IGH/CCND1 translocation and the TT genotype of the KIAA1524 gene (686C > T) (median PFS: 6 vs. 25 months; HR = 7.18). On the other hand, autologous haematopoietic stem cell transplantation (AHSCT) was related to a lower risk of early disease progression. Moreover, light chain disease, International Staging System (ISS) 3, poor performance status, hypoalbuminemia, IGH/FGFR3 translocation and the TT genotype of the KIAA1524 gene (686C > T) were independent prognostic factors associated with shorter overall survival (OS) (median OS: 8 vs. 45 months; HR = 7.08).

Conclusion

The evaluation of the SNP 686C > T of the KIAA1524 gene could be used as a diagnostic tool in MM patients at risk of early disease progression and death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationMultiple MyelomaHumansDisease ProgressionDisease-Free SurvivalGenotypeAutoantigensMembrane ProteinsIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

CIP2AMYCmolecular biomarkersmultiple myelomapolymorphismprognosis

Substanzen

CIP2A protein, humanAutoantigensMembrane ProteinsIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-059 Lublin, Poland.
  • Body Composition Research Laboratory, Department of Preclinical Sciences, Medical University of Lublin, 20-059 Lublin, Poland.
  • Department of Human Physiology, Medical University of Lublin, 20-059 Lublin, Poland.
  • Division of Mathematics, Department of Production Computerisation and Robotisation, Lublin University of Technology, 20-618 Lublin, Poland.
  • Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.
  • Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, 20-059 Lublin, Poland.

ORCID-Profile: Aneta Szudy-Szczyrek, Radosław Mlak, Marcin Mazurek, Tomasz Krajka, Sylwia Chocholska, Marta Jutrzenka, Andrzej Krajka

Förderung

  • Ministry of Science and Higher Education

Zitieren

APA

Szudy-Szczyrek, A., Mlak, R., Mazurek, M., Krajka, T., Chocholska, S., Bitkowska, P., Jutrzenka, M., Szczyrek, M., Homa-Mlak, I., Krajka, A., Małecka-Massalska, T., & Hus, M. (2023). The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma. Cells. https://doi.org/10.3390/cells12071029

Vancouver

Szudy-Szczyrek A, Mlak R, Mazurek M, Krajka T, Chocholska S, Bitkowska P, et al. The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma. Cells. 2023. doi:10.3390/cells12071029

BibTeX
@article{SzudySzczyrek2023,
  author = {Szudy-Szczyrek, Aneta and Mlak, Radosław and Mazurek, Marcin and Krajka, Tomasz and Chocholska, Sylwia and Bitkowska, Paulina and Jutrzenka, Marta and Szczyrek, Michał and Homa-Mlak, Iwona and Krajka, Andrzej and Małecka-Massalska, Teresa and Hus, Marek},
  title = {The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12071029}
}
Kostenlos starten →